SEC Form 4 · accession 0001209191-17-062227
XBiotech Inc. · XBIT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sushma Shivaswamy
Officer — Chief Scientific Officer
Period of report
Nov 20, 2017
Accepted (ET)
Nov 22, 2017 · 7:14 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001626878
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $4.13 | Nov 20, 2017 | A | 150,000 | A | Nov 20, 2018 | Nov 20, 2027 | Common Stock | 150,000 | 150,000 | D |
Explanation of responses
- F1On November 20, 2017 (the Grant Date) the reporting person was granted incentive stock options (the Options) under the Company's 2015 Equity Incentive Plan to purchase shares of the Company's Common Stock (the Shares) at an exercise price equal to the closing sales price of the Shares on the Grant Date as quoted by the Nasdaq Stock Market. The Options vest in three equal annual installments commencing as of the first anniversary of the Grant Date with an expiry of ten years from the Grant Date.